Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: A multivariate analysis of prognostic factors

Hepatology

Volumn 19, Issue 5, 1994, Pages 1115-1123

  Mondazzi, Luca ^a   Bottelli, Riccardo ^a   Brambilla, Giorgio ^a   Rampoldi, Antonio ^a   Rezakovic, Indira ^a   Zavaglia, Claudio ^a   Alberti, Alberto ^a   Idèo, Gaetano ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; GELATIN SPONGE; IODINATED POPPYSEED OIL; IOPAMIDOL; SPONGOSTAN;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BILIRUBIN BLOOD LEVEL; CANCER GRADING; CANCER RISK; CANCER SIZE; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

ACTUARIAL ANALYSIS; ADULT; AGE FACTORS; AGED; ALPHA-FETOPROTEINS; BILIRUBIN; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; GELATIN SPONGE, ABSORBABLE; HEPATIC ARTERY; HUMAN; IODIZED OIL; LIVER NEOPLASMS; MALE; MIDDLE AGE; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0028295731     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840190508     Document Type: Article

References (42)

1. Cirrhosis and the aetiology of hepatocellular carcinoma
2. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients
3. Natural history of hepatocellular carcinoma in Spain. Five years' experience in 249 cases
4. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients
5. Asymptomatic hepatocellular carcinoma in Child's A cirrhosis. A comparison of natural history and surgical treatment
6. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival
7. Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents
8. Primary treatment of hepatocellular carcinoma by arterial chemoembolization
9. Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: results of a western comparative study in 60 patients
10. Hepatic artery embolization in 120 patients with unresectable hepatoma
11. Combined peripheral and central chemoembolization of liver tumors. Experience with Lipiodoldoxorubicin and gelatin sponge (L‐TAE)
12. Clinical evaluation of hepatic artery embolization: comparison between gelfoam and Lipiodol with anticancer agent
13. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma
14. Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion
15. Hepatic artery embolization for inoperable hepatocellular carcinoma: prognosis and risk factors
16. Hepatocellular carcinoma: a multivariate analysis of prognostic features in patients treated with hepatic arterial embolization
17. Prognosis of unresectable hepatocellular carcinoma: an evaluation based on multivariate analysis of 90 cases
18. Treatment of hepatocellular carcinoma by trans‐catheter arterial chemoembolization and analysis of prognostic factors
19. Analysis of prognostic factors in patients with hepatocellular carcinoma treated by trans‐catheter arterial embolization
20. Postresection recurrence of hepatocellular carcinoma treated by arterial embolization: analysis of prognostic factors
21. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the Cox proportional hazard model
22. Confirmation of hepatitis C virus infection by new four‐antigen recombinant immunoblot assay
23. Transection of the oesophagus for bleeding oesophageal varices
24. Criteria of performance status
25. Hepatocellular carcinoma detected by iodized oil
26. A 5‐year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma
27. Nonparametric estimation from incomplete observations
28. Regression models and life tables (with discussion)
29. Survival analysis
30. Transcatheter oily chemoembolization of hepatocellular carcinoma
31. Relationship between serum alpha‐fetoprotein, cirrhosis and survival in hepatocellular carcinoma
32. Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy
33. Hepatocellular carcinoma. Prognostic factors and survival analysis in 135 Italian patients
34. Prognostic factors of hepatocellular carcinoma in the West: a multivariate analysis in 206 patients
35. Prognostic factors in patients with hepatocellular carcinoma. Attempts for the selection of patients with prolonged survival
36. Factors affecting the prognosis of primary liver carcinoma
37. Prognostic factors for survival in hepatocellular carcinoma
38. Hepatocellular carcinoma. Diagnostic and prognostic features in North American patients
39. Transcatheter arterial chemotherapy using doxorubicin iodized oil and Gelfoam embolization in hepatocellular carcinoma
40. Distribution of Lipiodol in hepatocellular carcinoma
41. Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings
42. Lipiodol retention and massive necrosis after Lipiodol‐chemoembolization of hepatocellular carcinoma: correlation between computed tomography and histopathology